Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

(2008) Keith H. Nuechterlein et al.   AMERICAN JOURNAL OF PSYCHIATRY

Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative

(2008) Cameron S. Carter et al.   BIOLOGICAL PSYCHIATRY

Cerebrospinal Fluid Dehydroepiandrosterone Levels Are Correlated with Brain Dehydroepiandrosterone Levels, Elevated in Alzheimer’s Disease, and Related to Neuropathological Disease Stage

(2008) Jennifer C. Naylor et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)

(2008) R KEEFE et al.   SCHIZOPHRENIA RESEARCH

Endogenous and synthetic neurosteroids in treatment of Niemann–Pick Type C disease

(2007) Synthia H. Mellon et al.   BRAIN RESEARCH REVIEWS

Progesterone exerts neuroprotective effects after brain injury

(2007) Donald G. Stein   BRAIN RESEARCH REVIEWS

The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production

(2007) Lena Danovich et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pregnenolone sulfate in the brain: A controversial neurosteroid

(2007) Michael Schumacher et al.   NEUROCHEMISTRY INTERNATIONAL

Differential hypothalamic–pituitary–adrenal activation of the neuroactive steroids pregnenolone sulfate and deoxycorticosterone in healthy controls and alcohol-dependent subjects

(2007) Patrizia Porcu et al.   PSYCHONEUROENDOCRINOLOGY